Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutch healthy population COVID-19 vaccine immune response monitoring study
NL-OMON51214Completed
- Sponsor
- Ministry of Health, Welfare and Sport
- Start
- May 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Ministry of Health, Welfare and Sport. Primary endpoint: COVID-19 vaccine-specific serum IgG geometric mean concentration at day 28 after completion of vaccination. Started May 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON51214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51214.